Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Hydrogen therapy may be an effective and specific novel treatment for aplastic anemia.

Qian L, Shen J, Cai J.

Med Sci Monit. 2012 Jun;18(6):HY19-22.

PMID:
22648259
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Hydrogen therapy may be an effective and specific novel treatment for acute graft-versus-host disease (GVHD).

Qian L, Shen J.

J Cell Mol Med. 2013 Aug;17(8):1059-63. doi: 10.1111/jcmm.12081. Epub 2013 Jun 7.

PMID:
23742028
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Special Education: Aplastic Anemia.

Teramura M, Mizoguchi H.

Oncologist. 1996;1(3):187-189.

PMID:
10387986
[PubMed - as supplied by publisher]
Free Article
4.

Hydrogen as a novel and effective treatment of acute carbon monoxide poisoning.

Shen M, He J, Cai J, Sun Q, Sun X, Huo Z.

Med Hypotheses. 2010 Aug;75(2):235-7. doi: 10.1016/j.mehy.2010.02.029. Epub 2010 Mar 29. Review.

PMID:
20347528
[PubMed - indexed for MEDLINE]
5.

Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors.

Găman A, Găman G, Bold A.

Rom J Morphol Embryol. 2009;50(4):669-74.

PMID:
19942964
[PubMed - indexed for MEDLINE]
Free Article
6.

First report of a B cell lymphoproliferative disorder arising in a patient treated with immune suppressants for severe aplastic anemia.

Dorr V, Doolittle G, Woodroof J.

Am J Hematol. 1996 Jun;52(2):108-13.

PMID:
8638630
[PubMed - indexed for MEDLINE]
7.

Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature.

Itterbeek P, Vandenberghe P, Nevens F, Fevery J, Aerts R, Yap SH, Demuynck H, Fourneau I, Koshiba T, Emonds MP, Roskams T, Boogaerts M, Pirenne J.

Transpl Int. 2002 Mar;15(2-3):117-23. Epub 2002 Mar 5. Review.

PMID:
11935168
[PubMed - indexed for MEDLINE]
8.

Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia.

Brodsky RA, Sensenbrenner LL, Smith BD, Dorr D, Seaman PJ, Lee SM, Karp JE, Brodsky I, Jones RJ.

Ann Intern Med. 2001 Oct 2;135(7):477-83.

PMID:
11578150
[PubMed - indexed for MEDLINE]
9.

Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia.

Hara T, Ando K, Tsurumi H, Moriwaki H.

Eur J Haematol. 2004 Jul;73(1):10-6.

PMID:
15182332
[PubMed - indexed for MEDLINE]
10.

Effect of interleukin 10 on the hematopoietic progenitor cells from patients with aplastic anemia.

Asano Y, Shibata S, Kobayashi S, Okamura S, Niho Y.

Stem Cells. 1999;17(3):147-51.

PMID:
10342557
[PubMed - indexed for MEDLINE]
Free Article
11.

[Influence of Shenmai injection on blood serum tumor necrosis factor and bone marrow CD34+ cell's apoptosis of chronic aplastic anemia patient].

Tang Q, Hu H, Zhang H.

Zhongguo Zhong Yao Za Zhi. 2005 Aug;30(16):1296-8. Chinese.

PMID:
16245914
[PubMed - indexed for MEDLINE]
12.

[Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].

Chen C, Fang JP, Huang SL, Zhong FY.

Zhonghua Er Ke Za Zhi. 2006 Nov;44(11):841-4. Chinese.

PMID:
17274875
[PubMed - indexed for MEDLINE]
13.

Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemia.

Demeter J, Messer G, Schrezenmeier H.

Ann Hematol. 2002 Oct;81(10):566-9. Epub 2002 Oct 11.

PMID:
12424537
[PubMed - indexed for MEDLINE]
14.

Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.

Tichelli A, Socié G, Henry-Amar M, Marsh J, Passweg J, Schrezenmeier H, McCann S, Hows J, Ljungman P, Marin P, Raghavachar A, Locasciulli A, Gratwohl A, Bacigalupo A.

Ann Intern Med. 1999 Feb 2;130(3):193-201.

PMID:
10049197
[PubMed - indexed for MEDLINE]
15.

Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.

Dubey S, Shukla P, Nityanand S.

Ann Hematol. 2005 Sep;84(9):572-7. Epub 2005 Apr 7.

PMID:
15815907
[PubMed - indexed for MEDLINE]
16.

Proposal for using small molecule tumor necrosis factor-alpha lowering agents, possibly bupropion, in aplastic anemia.

Kast RE, Altschuler EL.

Med Hypotheses. 2005;65(2):374-6.

PMID:
15922115
[PubMed - indexed for MEDLINE]
17.

Recurrent idiopathic acute hepatitis-associated aplastic anemia/pancytopenia fourteen years after initial episode.

Al Nahdi N, Wiesinger H, Sutherland H, Yoshida EM.

Ann Hepatol. 2010 Oct-Dec;9(4):468-70.

PMID:
21057169
[PubMed - indexed for MEDLINE]
18.

Cytokine serum levels during treatment with high-dose recombinant human IL-3 in a patient with severe aplastic anemia.

Nachbaur D, Gratwohl A, Herold M, Tichelli A, Slanicka M, Nissen C, Niederwieser D, Speck B.

Ann Hematol. 1993 Feb;66(2):71-5.

PMID:
8448242
[PubMed - indexed for MEDLINE]
19.

Abnormal immunity and stem/progenitor cells in acquired aplastic anemia.

Li JP, Zheng CL, Han ZC.

Crit Rev Oncol Hematol. 2010 Aug;75(2):79-93. doi: 10.1016/j.critrevonc.2009.12.001. Epub 2009 Dec 31. Review.

PMID:
20045349
[PubMed - indexed for MEDLINE]
20.

Interleukin-27 enhances the production of tumour necrosis factor-α and interferon-γ by bone marrow T lymphocytes in aplastic anaemia.

Li J, Zhao Q, Xing W, Feng J, Wu H, Li H, Ge M, Tian K, Li X, Zhou J, Liu B, Zhang L, Zheng Y, Han ZC.

Br J Haematol. 2011 Jun;153(6):764-72. doi: 10.1111/j.1365-2141.2010.08431.x. Epub 2011 Apr 21.

PMID:
21506940
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk